X0306 4 2022-08-19 0 0001831828 Vera Therapeutics, Inc. VERA 0001857670 Curley Joanne C/O VERA THERAPEUTICS, INC. 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 0 1 0 0 Chief Development Officer Class A Common Stock 2022-08-19 4 A 0 12500 0.00 A 29785 D Class A Common Stock 2022-08-19 4 M 0 378 6.3728 A 30163 D Class A Common Stock 2022-08-19 4 S 0 378 18.8854 D 29785 D Class A Common Stock 2022-08-19 4 M 0 700 6.3728 A 30485 D Class A Common Stock 2022-08-19 4 S 0 700 19.7607 D 29785 D Class A Common Stock 2022-08-19 4 M 0 710 2.8968 A 30495 D Class A Common Stock 2022-08-19 4 S 0 710 18.9312 D 29785 D Class A Common Stock 2022-08-19 4 M 0 1451 2.8968 A 31236 D Class A Common Stock 2022-08-19 4 S 0 1451 19.8685 D 29785 D Class A Common Stock 2022-08-19 4 M 0 2766 11.00 A 32551 D Class A Common Stock 2022-08-19 4 S 0 2766 18.6114 D 29785 D Class A Common Stock 2022-08-19 4 M 0 904 11.00 A 30689 D Class A Common Stock 2022-08-19 4 S 0 904 19.8055 D 29785 D Class A Common Stock 2022-08-22 4 M 0 1030 11.00 A 30815 D Class A Common Stock 2022-08-22 4 S 0 1030 18.4241 D 29785 D Class A Common Stock 2022-08-22 4 M 0 600 11.00 A 30385 D Class A Common Stock 2022-08-22 4 S 0 600 19.6457 D 29785 D Stock Option (right to buy) 6.3728 2022-08-19 4 M 0 1078 0.00 D 2030-03-31 Class A Common Stock 1078 12951 D Stock Option (right to buy) 2.8968 2022-08-19 4 M 0 2161 0.00 D 2030-12-15 Class A Common Stock 2161 44598 D Stock Options (right to buy) 11.00 2022-08-19 4 M 0 3670 0.00 D 2031-05-12 Class A Common Stock 3670 104547 D Stock Options (right to buy) 11.00 2022-08-22 4 M 0 1630 0.00 D 2031-05-12 Class A Common Stock 1630 102917 D Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") under Issuer's 2021 Equity Incentive Plan. One-third of the RSUs vest on August 20, 2023, rounded to the nearest whole share, and the remaining RSUs vest on August 20, 2024, subject to the Reporting Person's continuous service through each vesting date. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022. The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $18.49 to $19.24, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $19.56 to $20.00, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $18.50 to $19.30, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $19.70 to $20.02, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $18.24 to $19.23, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $19.56 to $20.21, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $18.20 to $18.75, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $19.45 to $19.91, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. 1/4 of the shares subject to the option vested on March 12, 2021, and 1/48 of the shares vest monthly thereafter. 1/4 of the shares subject to the option vest on December 16, 2021, and 1/48 of the shares vest monthly thereafter. 1/4 of the shares subject to the option vest on May 13, 2022, and 1/48 of the shares vest monthly thereafter. Exhibit List: Exhibit 24 - Power of Attorney /s/ Joseph R. Young, Attorney-in-Fact 2022-08-23